share_log

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga ·  00:34

Gainers

  • Sonnet BioTherapeutics (NASDAQ:SONN) stock moved upwards by 77.9% to $7.49 during Wednesday's regular session. The company's market cap stands at $38.9 million.
  • Cytek Biosciences (NASDAQ:CTKB) shares moved upwards by 29.22% to $7.03. The company's market cap stands at $924.4 million. As per the press release, Q3 earnings came out yesterday.
  • Treace Medical Concepts (NASDAQ:TMCI) stock increased by 23.78% to $7.13. The market value of their outstanding shares is at $443.4 million. As per the press release, Q3 earnings came out yesterday.
  • RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 21.63% to $2.98. The company's market cap stands at $104.0 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 21.26% to $0.34. The market value of their outstanding shares is at $10.5 million.
  • OptimizeRx (NASDAQ:OPRX) stock increased by 16.24% to $5.94. The company's market cap stands at $108.8 million.

Losers

  • Tango Therapeutics (NASDAQ:TNGX) stock declined by 39.6% to $3.13 during Wednesday's regular session. The company's market cap stands at $335.3 million. As per the press release, Q3 earnings came out today.
  • PACS Group (NYSE:PACS) shares decreased by 39.39% to $17.91. The market value of their outstanding shares is at $2.7 billion.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock declined by 31.98% to $0.09. The market value of their outstanding shares is at $1.5 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares declined by 31.5% to $1.74. The market value of their outstanding shares is at $1.8 million.
  • Exact Sciences (NASDAQ:EXAS) stock decreased by 27.36% to $51.95. The company's market cap stands at $9.5 billion. The company's, Q3 earnings came out yesterday.
  • Lantheus Holdings (NASDAQ:LNTH) stock decreased by 22.71% to $88.86. The market value of their outstanding shares is at $6.1 billion. As per the news, the Q3 earnings report came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment